Article
Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorder.
Human psychopharmacology - 1 Jun 2008
Adams David H, Close Sandra, Farmen Mark, Downing Anncatherine M, Breier Alan, Houston John P
Abstract excerpt
OBJECTIVE: To test association of dopamine receptor D3 (DRD-3) gene polymorphisms with olanzapine response in genetic samples from a registration phase clinical trial. METHODS: Eighty-eight acutely ill patients with schizophrenia or schizoaffective disorder were genotyped for ser-9-gly (rs6280) a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
